NCT04816812

Brief Summary

The investigators aim to investigate whether exercise therapy during 12 weeks including a lesson on general healthy lifestyle in adult patients with a moderately active disease is more effective, compared to control patients only receiving a lesson on general healthy lifestyle recommendations. The three main categories of outcomes are 1) health-related quality of life, 2) general health status of the patients 3) explorative outcomes. The primary outcome is health-related quality of life, the secondary outcome is general health status measured by waist circumference, disease activity scores, blood pressure, and blood lipids, and the third outcome are explorative outcomes (none-disease specific quality of life scores, biomarkers of C-reactive protein, fecal calprotectin and immunology markers including interleukins).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

November 15, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

December 4, 2023

Status Verified

December 1, 2023

Enrollment Period

1.5 years

First QC Date

March 19, 2021

Last Update Submit

December 1, 2023

Conditions

Keywords

Exercise

Outcome Measures

Primary Outcomes (1)

  • Inflammatory Bowel Disease Questionnaire (IBDQ)

    Health-related quality of life

    12 weeks

Secondary Outcomes (4)

  • General health - Waist circumference

    12 weeks

  • General health - blood pressure

    12 weeks

  • General health - Lipid

    12 weeks

  • General health - Clinical disease activity

    12 weeks

Other Outcomes (2)

  • Explorative - European Quality of life

    12 weeks

  • Explorative - Biomarkers

    12 weeks

Study Arms (2)

Exercise

OTHER

In the intervention arm, a 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level.

Behavioral: Exercise interventionBehavioral: Lifestyle - online lesson intervention

Comparison

OTHER

Comparison

Behavioral: Lifestyle - online lesson intervention

Interventions

A 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level. This includes two supervised exercise sessions of 60 minutes per week, combined with one weekly home training session. The type of exercise is planned by a physiotherapist to fit each patient during sessions. We monitor the intervention by training diaries including frequency, intensity, time, and type of exercise (FITT) and the verbal BORG 15-point scale and heart rate monitors. We will also monitor the overall seven days' physical activity level by accelerometry using the AX3 device from the company Axivity at weeks 0 and 12.

Exercise

The investigators offer one online lesson of 15-25 minutes on lifestyle guidance including general advice on healthy living.

ComparisonExercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with moderately active Crohn's disease or ulcerative colitis are defined by fulfilling all the following five criteria:
  • Well-characterized Crohn's disease or ulcerative colitis (physician assessment) i. Fulfilling standard clinical, endoscopic, radiologic, and histological criteria
  • i. Usage of 5-Aminosalicylic acid (5-ASA) ii. Usage of corticosteroids iii. Immunomodulators usage: Azathioprine (AZA), 6-mercaptopurine (6-MP), Methotrexate (MTX) iv. Biologics usage: Anti-TNFα (Infliximab, Adalimumab, Golimumab), Ustekinumab or Anti-integrin (Vedolizumab)
  • Disease activity defined by clinical disease score:
  • i. Harvey Bradshaw Index (HBI) 27 \> 5 ii. Simple Clinical Colitis Activity Index (SCCAI) 29 \> 5
  • Marker for gastrointestinal inflammation:
  • i. Fecal calprotectin (FC) \> 200 mg/g

You may not qualify if:

  • \. A language barrier that prohibits the exercise instructors/supervisors to give sufficient or safe instructions during the intervention or at the general health lesson.
  • \. Known heart condition that prevents them to actively participate safely in the exercise intervention.
  • \. Known pregnancy or planned pregnancy. 4. Disabling musculoskeletal injuries that prevent them to actively participate in the exercise intervention.
  • \. Severe disease activity manifested clinically and with the need for urgent change in treatment evaluated by the responsible physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital of Southwest Jutland

Esbjerg, Denmark

Location

Odense University Hospital

Odense, Denmark

Location

Related Publications (7)

  • Elia J, Kane S. Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise. Inflamm Bowel Dis. 2018 Nov 29;24(12):2543-2549. doi: 10.1093/ibd/izy199.

    PMID: 29850914BACKGROUND
  • Shephard RJ. The Case for Increased Physical Activity in Chronic Inflammatory Bowel Disease: A Brief Review. Int J Sports Med. 2016 Jun;37(7):505-15. doi: 10.1055/s-0042-103157. Epub 2016 Apr 26.

    PMID: 27116344BACKGROUND
  • Eckert KG, Abbasi-Neureither I, Koppel M, Huber G. Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease - a scoping review and practical implications. BMC Gastroenterol. 2019 Jul 2;19(1):115. doi: 10.1186/s12876-019-1034-9.

    PMID: 31266461BACKGROUND
  • Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wojcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep. 2016 Aug;68(4):827-36. doi: 10.1016/j.pharep.2016.04.009. Epub 2016 May 2.

    PMID: 27255494BACKGROUND
  • Reed JL, Pipe AL. Practical Approaches to Prescribing Physical Activity and Monitoring Exercise Intensity. Can J Cardiol. 2016 Apr;32(4):514-22. doi: 10.1016/j.cjca.2015.12.024. Epub 2015 Dec 29.

    PMID: 26897182BACKGROUND
  • Bandholm T, Christensen R, Thorborg K, Treweek S, Henriksen M. Preparing for what the reporting checklists will not tell you: the PREPARE Trial guide for planning clinical research to avoid research waste. Br J Sports Med. 2017 Oct;51(20):1494-1501. doi: 10.1136/bjsports-2017-097527. Epub 2017 Sep 7. No abstract available.

    PMID: 28882839BACKGROUND
  • Lund K, Knudsen T, Kjeldsen J, Nielsen RG, Juhl CB, Norgard BM. The IBD-FITT study - moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial. Trials. 2023 Nov 20;24(1):742. doi: 10.1186/s13063-023-07781-4.

MeSH Terms

Conditions

Inflammatory Bowel DiseasesMotor Activity

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesBehavior

Study Officials

  • Ken Lund, PhD

    Odense University Hospital & University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigators will apply a superior trial design in this randomized clinical trial with two arms, intervention, and comparison.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 25, 2021

Study Start

November 15, 2021

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

December 4, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations